|
Basis of Presentation (Details 2) (USD $)
In Thousands, except Per Share data, unless otherwise specified |
0 Months Ended | 1 Months Ended | 9 Months Ended | 1 Months Ended | 1 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Sep. 19, 2014
|
Aug. 29, 2014
|
Jun. 02, 2014
|
Apr. 07, 2014
|
Jun. 30, 2014
|
Sep. 30, 2014
|
Sep. 30, 2013
|
Jun. 26, 2014
Common Stock
|
Jun. 30, 2014
Common Stock
Fosun Pharma [Member]
|
Jun. 26, 2014
Common Stock
Fosun Pharma [Member]
|
Jun. 30, 2014
China Joint Venture [Member]
|
Jun. 30, 2014
China Joint Venture [Member]
Fosun Pharma [Member]
|
Jun. 26, 2014
China Joint Venture [Member]
Fosun Pharma [Member]
item
|
|
| Strategic Allliance and Formation of China Joint Venture [Line Items] | |||||||||||||
| Proceeds from Issuance of Private Placement | $ 46,216 | ||||||||||||
| Dividends Payable, Amount Per Share | $ 1.50 | ||||||||||||
| Dividends payable to shareholders | 28,501 | ||||||||||||
| Payments of Dividends | 28,501 | 1,619 | 1,619 | 1,618 | 33,357 | 28,797 | |||||||
| Shares, Issued | 2,855 | ||||||||||||
| Share Price | $ 16.19 | ||||||||||||
| Premium to Entity Average Stock Price for the Trailing Thirty Day Period | 10.00% | ||||||||||||
| Period of Time to Measure Premium of Entity Common Stock | 30 days | ||||||||||||
| Related Party Ownership Percentage After Common Stock Purchase | 15.00% | ||||||||||||
| Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions | 80.00% | 20.00% | |||||||||||
| Initial Capitalization Amount | $ 20,000 | $ 16,000 | |||||||||||
| Number of Board of Directors Initially Appointed | 1 | ||||||||||||